Sign In
Buy MDT
$77.95
+4.20 (+5.69%)
At Close: Jun 03, 2026
Medtronic CEO: More companies are spinning off problems, we're spinning off an attractive asset
12:11pm, Wednesday, 21'st May 2025
Geoff Martha, Medtronic CEO, joins 'Money Movers' to discuss the company's spinoff plans, growth strategy and surgical robotics.
Compared to Estimates, Medtronic (MDT) Q4 Earnings: A Look at Key Metrics
10:31am, Wednesday, 21'st May 2025
Although the revenue and EPS for Medtronic (MDT) give a sense of how its business performed in the quarter ended April 2025, it might be worth considering how some key metrics compare with Wall Street
Medtronic to split off its fast-growing diabetes business to unlock its value
10:00am, Wednesday, 21'st May 2025
The new diabetes company will be predominantly business-to-consumer, while Medtronic's model was more business-to-business.
Medtronic (MDT) Q4 Earnings and Revenues Beat Estimates
08:56am, Wednesday, 21'st May 2025
Medtronic (MDT) came out with quarterly earnings of $1.62 per share, beating the Zacks Consensus Estimate of $1.58 per share. This compares to earnings of $1.46 per share a year ago.
Medtronic Dips Despite Quarterly Beat On Plans To Spin Off Diabetes Business
08:51am, Wednesday, 21'st May 2025
Medtronic stock fell early Wednesday despite beating forecasts after the company said it plans to spin off its diabetes business.
Medtronic reports strong finish to its fiscal year with its fourth quarter financial results; announces dividend increase
06:45am, Wednesday, 21'st May 2025
Building momentum in key franchises including Pulsed Field Ablation, TAVR, Cardiac Rhythm Management, Diabetes, Spine, and Neuromodulation GALWAY, Ireland , May 21, 2025 /PRNewswire/ -- Medtronic plc
Medtronic announces intent to separate Diabetes business
06:44am, Wednesday, 21'st May 2025
Enables intense focus on highest margin growth drivers where Medtronic has leading core competencies Leading, scaled, direct-to-consumer Diabetes business poised to become standalone company; only com
Medtronic to separate diabetes business, WSJ reports
05:18am, Wednesday, 21'st May 2025
Medical device maker Medtronic plans to separate its diabetes business into a stand-alone company, the Wall Street Journal reported on Wednesday, citing people familiar with the matter.
Medtronic to Separate Diabetes Business
05:00am, Wednesday, 21'st May 2025
The medical device maker has been working to turn around the division over the last few years.
Will Medtronic's Earnings Move The Stock?
05:35am, Monday, 19'th May 2025
Medtronic (NYSE:MDT) is scheduled to announce its earnings on Wednesday, May 21, 2025. Over the last five years, Medtronic's stock has shown a favorable one-day return following its earnings announcem
Don't Fall for These 3 Dividend Stocks: They May Have to Make a Cut.
12:05pm, Sunday, 18'th May 2025
Dividend stocks can be a smart way to generate steady income, especially in uncertain markets. However, not all dividend payers are created equal.
Trump tariff 'tornado' still hunting markets: Former Medtronic CEO
10:38am, Friday, 16'th May 2025
You can catch Opening Bid on Apple Podcasts, Spotify, YouTube, or wherever you get your podcasts. There has been one common theme from Corporate America throughout the last two months as the Trump adm
What Analyst Projections for Key Metrics Reveal About Medtronic (MDT) Q4 Earnings
10:21am, Friday, 16'th May 2025
Get a deeper insight into the potential performance of Medtronic (MDT) for the quarter ended April 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for som
Should You Continue to Hold Medtronic Stock in Your Portfolio Now?
08:51am, Friday, 16'th May 2025
Investors stay optimistic about MDT due to its strength in the Cardiovascular portfolio.
Medtronic (MDT) Stock Declines While Market Improves: Some Information for Investors
06:50pm, Wednesday, 14'th May 2025
Medtronic (MDT) closed the most recent trading day at $84.25, moving -1.01% from the previous trading session.
